T2 Biosystems Announces Issuance of Key Patent Providing Broad Intellectual Property Protection for Direct Detection Diagnostic Methods
2/2/2012 7:36:43 AM
LEXINGTON, Mass.--(BUSINESS WIRE)--T2 Biosystems, a company developing direct detection products enabling superior diagnostics, today announced the issuance of patent number 8,102,176 by the United States Patent and Trademark Office entitled “NMR Device for Detection of Analytes”. The patent broadly covers devices and methods of detecting analytes through magnetic resonance measurement, the basis for T2 Bio’s technology. The T2MR technology is capable of directly detecting any immunologic, hemostasis, or molecular target, most recently demonstrated with rapid and accurate direct detection of Candida from whole blood samples.